146 related articles for article (PubMed ID: 1320929)
1. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
Chao BH; Kalkunte S; Maraganore JM; Stone SR
Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
[TBL] [Abstract][Full Text] [Related]
2. 'Tethered ligand' derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for human platelet activation and GTPase stimulation.
Natarajan S; Riexinger D; Peluso M; Seiler SM
Int J Pept Protein Res; 1995 Feb; 45(2):145-51. PubMed ID: 7782162
[TBL] [Abstract][Full Text] [Related]
3. Minimal sequence requirement of thrombin receptor agonist peptide.
Hui KY; Jakubowski JA; Wyss VL; Angleton EL
Biochem Biophys Res Commun; 1992 Apr; 184(2):790-6. PubMed ID: 1315534
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.
Van Obberghen-Schilling E; Rasmussen UB; Vouret-Craviari V; Lentes KU; Pavirani A; Pouysségur J
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):667-71. PubMed ID: 7686363
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity studies of the thrombin receptor activating peptide.
Sabo T; Gurwitz D; Motola L; Brodt P; Barak R; Elhanaty E
Biochem Biophys Res Commun; 1992 Oct; 188(2):604-10. PubMed ID: 1332704
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.
Vassallo RR; Kieber-Emmons T; Cichowski K; Brass LF
J Biol Chem; 1992 Mar; 267(9):6081-5. PubMed ID: 1313429
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase.
Seiler SM; Michel IM; Fenton JW
Biochem Biophys Res Commun; 1992 Feb; 182(3):1296-302. PubMed ID: 1371679
[TBL] [Abstract][Full Text] [Related]
8. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment.
Norton KJ; Scarborough RM; Kutok JL; Escobedo MA; Nannizzi L; Coller BS
Blood; 1993 Oct; 82(7):2125-36. PubMed ID: 8400262
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
11. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
[TBL] [Abstract][Full Text] [Related]
12. Indications for the presence of an atypical protease-activated receptor on rat platelets.
Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
[TBL] [Abstract][Full Text] [Related]
13. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets.
Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A
J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
Lau LF; Pumiglia K; Côté YP; Feinstein MB
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
[TBL] [Abstract][Full Text] [Related]
17. Response of blood leukocytes to thrombin receptor peptides.
Hoffman M; Church FC
J Leukoc Biol; 1993 Aug; 54(2):145-51. PubMed ID: 8395550
[TBL] [Abstract][Full Text] [Related]
18. Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M.
Coller BS; Ward P; Ceruso M; Scudder LE; Springer K; Kutok J; Prestwich GD
Biochemistry; 1992 Dec; 31(47):11713-20. PubMed ID: 1359906
[TBL] [Abstract][Full Text] [Related]
19. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of a platelet receptor peptide bound to bovine alpha-thrombin.
Ni F; Ripoll DR; Martin PD; Edwards BF
Biochemistry; 1992 Nov; 31(46):11551-7. PubMed ID: 1332764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
